GNOMvsSPYG
Global X Genomics & Biotechnology ETF against SPDR Portfolio S&P 500 Growth ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| GNOM | SPYG | |
|---|---|---|
| Expense ratio | 0.50% | 0.040% |
| Assets | $85M | $54.7B |
| Net flow, 1 month | — | +$762M |
| Net flow, 1 year | — | +$4.9B |
| Return, YTD | +46.2% | +11.9% |
| Return, 1 year | — | — |
| Avg daily volume | 39K | 2.3M |
| Holdings | 41 | 228 |
| Listed | Apr 5, 2019 | Sep 25, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS